APA (7th ed.) Citation

H, D., B, B., & B, T. (2026). Knockdown of miR-182 changes the sensitivity of triple-negative breast cancer cells to cisplatin. Nucleosides, nucleotides & nucleic acids, 45(1), 35. https://doi.org/10.1080/15257770.2025.2451818

Chicago Style (17th ed.) Citation

H, Dönmez, Batar B, and Turgut B. "Knockdown of MiR-182 Changes the Sensitivity of Triple-negative Breast Cancer Cells to Cisplatin." Nucleosides, Nucleotides & Nucleic Acids 45, no. 1 (2026): 35. https://doi.org/10.1080/15257770.2025.2451818.

MLA (9th ed.) Citation

H, Dönmez, et al. "Knockdown of MiR-182 Changes the Sensitivity of Triple-negative Breast Cancer Cells to Cisplatin." Nucleosides, Nucleotides & Nucleic Acids, vol. 45, no. 1, 2026, p. 35, https://doi.org/10.1080/15257770.2025.2451818.